ILIKOS Consulting Group Expands International Operations with New Greek Office
PAPHOS, Cyprus, April 28, 2025 — ILIKOS Consulting Group, a prominent player in the commercial strategy and corporate development space for Contract Research Organizations (CROs), has officially announced the launch of its latest subsidiary in Greece. This significant move reflects the company’s strategic initiative to bolster its international growth and broaden its array of business solutions.
The establishment of the Greek subsidiary is a response to a surge in demand and favorable growth outcomes within the region. ILIKOS aims to strengthen its support for existing clients while also nurturing new partnerships in the rapidly evolving clinical research landscape in Greece. The subsidiary is set to leverage the group's extensive expertise in commercial strategic planning and business development activities in the domain of clinical research.
Elias Sayias, Founder and CEO of ILIKOS Consulting Group, expressed his enthusiasm about this expansion: "We are thrilled to extend our presence into Greece, reflecting our dedication to promoting local talent and innovation. This expansion aligns with our growth strategy and reinforces our commitment to empowering our Clients and community alike to achieve their growth objectives."
Greece is undergoing a remarkable transformation characterized by robust economic growth, an emerging startup ecosystem, and significant investments in critical sectors. The new Athens-based subsidiary will fit seamlessly into this dynamic business environment. This expansion is expected to generate valuable employment opportunities, integrating a highly educated workforce into the local economy and providing new career pathways.
ILIKOS Consulting Group has made a name for itself by offering flexible, adaptive, and highly personalized services tailored to the needs of CROs and life-science enterprises. Their expertise lies in crafting and implementing effective commercial business development strategies while addressing various challenges such as cost efficiency, quality, consistency, and alignment with evolving market trends.
The decision to expand into Greece signals ILIKOS's confidence in the country’s potential as a hub for clinical research and innovation. This step not only enhances the company's portfolio but also positions it strategically to tap into the new opportunities that arise within the local market.
As the global market continues to diversify, ILIKOS Consulting Group’s focus on local partnerships and capacity building reaffirms its commitment to driving impactful growth both for its clients and the communities in which it operates.
For more information about ILIKOS Consulting Group and their services, visit
www.goilikos.com.
To reach out for inquiries, contact Elias Sayias, BSc. CCRA, at [email protected]